The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation studySTEWART, W. A; PEARCE, R; RUSSELL, N et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 11, pp 1587-1593, issn 0268-3369, 7 p.Article

Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents-is it possible?FARACI, M; DINI, G.Bone marrow transplantation. Supplement (Basingstoke). 2008, Vol 42, Num 2, issn 0951-3078, S90-S96Conference Paper

Autotransplant conditioning regimens for aggressive lymphoma : are we on the right road?FERNANDEZ, H. F; ESCALON, M. P; PEREIRA, D et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 6, pp 505-513, issn 0268-3369, 9 p.Article

Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignanciesSUREDA, A; SCHMITZ, N.Annals of hematology (Print). 2003, Vol 82, Num 1, pp 1-13, issn 0939-5555, 13 p.Article

Optimization of allogeneic transplant conditioning : not the time for dogma : Reduced-intensity conditioning allogeneic stem cell transplantation: hype, reality or time for a rethink?DEEG, H. J; MARIS, M. B; SCOTT, B. L et al.Leukemia. 2006, Vol 20, Num 10, pp 1701-1705, issn 0887-6924, 5 p.Article

Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and concurrent lymphoid malignancyZIMMERMAN, Z; SCOTT, B. L; GOPAL, A. K et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 6, pp 804-809, issn 0268-3369, 6 p.Article

Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remissionMARTINO, R; VALCARCEL, D; BRUNET, S et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 1, pp 33-38, issn 0268-3369, 6 p.Article

Chimerism analysis within 6 months of allogeneic stem cell transplantation predicts relapse in acute myeloid leukemiaHUISMAN, C; DE WEGER, R. A; DE VRIES, L et al.Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 5, pp 285-291, issn 0268-3369, 7 p.Article

Busulfan 12 mg/kg plus melphalan 140 mg/m² versus melphalan 200 mg/m² as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 studyLAHUERTA, Juan José; MATEOS, Maria Victoria; CARRERA, Dolores et al.Haematologica (Roma). 2010, Vol 95, Num 11, pp 1913-1920, issn 0390-6078, 8 p.Article

Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trialLAHUERTA, Juan José; GRANDE, Carlos; BARGAY, Juan et al.British journal of haematology. 2003, Vol 120, Num 2, pp 296-303, issn 0007-1048, 8 p.Article

Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donorsSYMONS, H. J; FUCHS, E. J.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 6, pp 365-377, issn 0268-3369, 13 p.Article

Current Status of Allogeneic Hematopoietic Cell Transplantation for MDS : New Treatment Strategy of the Myelodysplastic SyndromesFENG XU; DEEG, H. Joachim.Current pharmaceutical design (Print). 2012, Vol 18, Num 22, pp 3215-3221, issn 1381-6128, 7 p.Article

Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow graftsFUCHS, Ephraim J.Current opinion in hematology. 2012, Vol 19, Num 6, pp 440-447, issn 1065-6251, 8 p.Article

BU and CY as conditioning regimen for autologous transplant in patients with multiple myelomaTALAMO, G; CLAXTON, D. F; DOUGHERTY, D. W et al.Bone marrow transplantation (Basingstoke). 2009, Vol 44, Num 3, pp 157-161, issn 0268-3369, 5 p.Article

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasiaUBERTI, J. P; AGOVI, M.-A; COPELAN, E et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 1, pp 34-43, issn 0268-3369, 10 p.Article

Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survivalDE WITTE, Theo; BRAND, Ronald; HARLAHAKIS, Nicolas et al.British journal of haematology. 2009, Vol 146, Num 6, pp 627-636, issn 0007-1048, 10 p.Article

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults : experience in Europe and the United StatesAVERSA, F.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 5, pp 473-481, issn 0268-3369, 9 p.Article

Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimensAL-HAZZOURI, A; CAO, Q; BURNS, L. J et al.Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 12, pp 949-951, issn 0268-3369, 3 p.Article

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse modelSADEGHI, B; JANSSON, M; HASSAN, Z et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 10, pp 895-904, issn 0268-3369, 10 p.Article

Unrelated donor hematopoietic cell transplantation for hemophagocytic lymphohistiocytosisBAKER, K. S; FILIPOVICH, A. H; EAPEN, M et al.Bone marrow transplantation (Basingstoke). 2008, Vol 42, Num 3, pp 175-180, issn 0268-3369, 6 p.Article

Expanding the role of umbilical cord blood transplantationBRUNSTEIN, Claudio G; SETUBAL, Daniela C; WAGNER, John E et al.British journal of haematology. 2007, Vol 137, Num 1, pp 20-35, issn 0007-1048, 16 p.Article

Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantationLAROSA, F; MARMIER, C; TIBERGHIEN, P et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 9, pp 859-868, issn 0268-3369, 10 p.Article

Omega-3 from fish oil augments GVHD through the enhancement of chemotherapy conditioning regimen and selective FoxP3 depletionAL HASHMI, S; SADEGHI, B; HASSAN, Z et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 6, pp 843-848, issn 0268-3369, 6 p.Article

Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimensJIMENEZ, M; ERCILLA, G; MARTINEZ, C et al.Leukemia. 2007, Vol 21, Num 8, pp 1628-1637, issn 0887-6924, 10 p.Article

Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioningMAJHAIL, N. S; PARKS, K; DEFOR, T. E et al.Bone marrow transplantation (Basingstoke). 2006, Vol 38, Num 11, pp 765-768, issn 0268-3369, 4 p.Article